DuPont Decomposition
Why does VIVIMEDLAB earn its ROE?
Breaking down Return on Equity into profitability, efficiency, and leverage.
ROE = Net Margin × Asset Turnover × Equity Multiplier
-18.6% = -28.6% × 0.19 × 3.48
Latest: FY2022
Profitability
Net Margin
-28.6%
-28.6% →-28.6%
How much profit per ₹ of revenue
Efficiency
Asset Turnover
0.19x
0.19x →0.19x
Revenue per ₹ of assets
Leverage
Equity Multiplier
3.48x
3.48x →3.48x
Assets funded by equity vs debt
Historical Decomposition
Last 1 years
| Year | Revenue | PAT | Net Margin | Asset TO | Leverage | ROE |
|---|---|---|---|---|---|---|
| FY2022 | ₹0Cr | ₹-0Cr | -28.6% | 0.19 | 3.48 | -18.6% |
How to read DuPont
- • Rising ROE from margin = pricing power, operational improvement (good)
- • Rising ROE from turnover = better asset utilization (good)
- • Rising ROE from leverage = more debt, amplified risk (caution)
- • Falling ROE across all three = structural deterioration (red flag)
DuPont decomposition from audited annual financials. Factual analysis, not investment advice.